MEDIHALER ERGOTAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Medihaler Ergotamine patents expire, and what generic alternatives are available?
Medihaler Ergotamine is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER ERGOTAMINE is ergotamine tartrate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
Summary for MEDIHALER ERGOTAMINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 7 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEDIHALER ERGOTAMINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MEDIHALER ERGOTAMINE
US Patents and Regulatory Information for MEDIHALER ERGOTAMINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | MEDIHALER ERGOTAMINE | ergotamine tartrate | AEROSOL, METERED;INHALATION | 012102-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |